Myelomas
Frontline T-cell engager vs Autologous Stem cell Transplant and measurable residual disease (MRD)-guided sequential intensification thERapy in multiple myeloma (FASTER) (MM 195)
- Details
ClinicalTrials.gov ID:
NCT06974786
Diagnosis Type:
NA
USOR Number:
- Address
,
P: